Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review

• Published in: Nutrients 2020-02, Vol.12 (2), p.521
• Main Authors: Ismail, Maznah, Alsalahi, Abdulsamad, Imam, Mustapha Umar, Ooi, Der Jiun, Khaza'ai, Huzwah, Aljaberi, Musheer A, Shamsudin, Mad Nasir, Idrus, Zulkifli
• Format: Article
• Language: English
• Subjects: Alzheimer Disease - metabolism; Alzheimer Disease - psychology; Alzheimer Disease - therapy; Alzheimer's disease; Amyloid beta-Peptides - metabolism; Animal diseases; Animal models; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Attenuation; Bias; Bibliographic literature; Boolean algebra; Cell culture; Cells, Cultured; Chemical Fractionation; Cognition - drug effects; Cognitive ability; Diabetes mellitus; Disease Models, Animal; Gene expression; Health services; Humans; Inflammation; Intervention; Isomers; Literature reviews; Mice; Natural products; Nervous system; Neurodegeneration; Neuroprotection; Neuroprotective Agents; Neurotoxins; Oils & fats; Operators (mathematics); Oxidative stress; Oxidative Stress - drug effects; Palm oil; Palm Oil - chemistry; Palm Oil - pharmacology; Palm Oil - therapeutic use; Phytotherapy; Pretreatment; Proteins; Rats; Review; Reviews; Systematic review; Tocotrienols - isolation & purification; Tocotrienols - pharmacology; Tocotrienols - therapeutic use; Toxins; Transgenic animals; Vegetable oils; Vitamin E; β-Amyloid
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu12020521

Several natural products have been reported to elicit beneficial effects against neurodegenerative disorders due to their vitamin E contents. However, the neuroprotective efficacy of palm oil or its tocotrienol-rich fraction (TRF) from the pre-clinical cell and animal studies have not been systematically reviewed. The protocol for this systematic review was registered in "PROSPERO" (CRD42019150408). This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The Medical Subject Heading (MeSH) descriptors of PubMed with Boolean operators were used to construct keywords, including ("Palm Oil"[Mesh]) AND "Nervous System"[Mesh], ("Palm Oil"[Mesh]) AND "Neurodegenerative Diseases"[Mesh], ("Palm Oil"[Mesh]) AND "Brain"[Mesh], and ("Palm Oil"[Mesh]) AND "Cognition"[Mesh], to retrieve the pertinent records from PubMed, Scopus, Web of Science and ScienceDirect from 1990 to 2019, while bibliographies, ProQuest and Google Scholar were searched to ensure a comprehensive identification of relevant articles. Two independent investigators were involved at every stage of the systematic review, while discrepancies were resolved through discussion with a third investigator. All of the 18 included studies in this review (10 animal and eight cell studies) showed that palm oil and TRF enhanced the cognitive performance of healthy animals. In diabetes-induced rats, TRF and α-tocotrienol enhanced cognitive function and exerted antioxidant, anti-apoptotic and anti-inflammatory activities, while in a transgenic Alzheimer's disease (AD) animal model, TRF enhanced the cognitive function and reduced the deposition of β-amyloid by altering the expression of several genes related to AD and neuroprotection. In cell studies, simultaneous treatment with α-tocotrienols and neurotoxins improved the redox status in neuronal cells better than ϒ- and δ-tocotrienols. Both pre-treatment and post-treatment with α-tocotrienol relative to oxidative insults were able to enhance the survival of neuronal cells via increased antioxidant responses. Palm oil and its TRF enhanced the cognitive functions of healthy animals, while TRF and α-tocotrienol enhanced the cognitive performance with attenuation of oxidative stress, neuroinflammation and apoptosis in diabetes-induced or transgenic AD animal models. In cell studies, TRF and α-tocotrienol exerted prophylactic neuroprotective effects, while α-tocotrienol exerted therapeutic neuroprotective effects th